Cargando…

Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein

BACKGROUND: Heptaplatin is a new platinum derivative with anticancer activity against various cancer cell lines, including cisplatin-resistant cancer cell lines (Cancer Chemother Pharmacol 1995; 35: 441). METHODS: Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Cheol-Hee, Cha, Yoon-Jung, An, Chun-San, Kim, Kyung-Jong, Kim, Kweon-Cheon, Moon, Sung-Pyo, Lee, Zang Hee, Min, Young-Don
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC533863/ https://www.ncbi.nlm.nih.gov/pubmed/15494073 http://dx.doi.org/10.1186/1475-2867-4-6

Ejemplares similares

Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer
por: Min, Young Joo, et al.
Publicado: (2004)

SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
por: Zhang, Yongli, et al.
Publicado: (2016)

The effects of MOTILIPERM on cisplatin induced testicular toxicity in Sprague–Dawley rats
por: Soni, Kiran Kumar, et al.
Publicado: (2015)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression
por: Calogero, Antonella, et al.
Publicado: (2011)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Rodrigo, Miguel Angel Merlos, et al.
Publicado: (2021)

Functional and structural characteristics of anticancer peptide Pep27 analogues
por: Lee, Dong Gun, et al.
Publicado: (2005)

ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231
por: Zhang, Yuzhu, et al.
Publicado: (2018)

Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance
por: Lv, Huimin, et al.
Publicado: (2021)

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma
por: Borchert, Sabrina, et al.
Publicado: (2020)

N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity
por: Keenan, Bryce, et al.
Publicado: (2020)

Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines
por: Min, Seon Ok, et al.
Publicado: (2015)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy
por: Kim, Yoonjung, et al.
Publicado: (2021)

Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells
por: Osman, Abdel-Moneim M., et al.
Publicado: (2015)

Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines
por: Wang, Yuanyuan, et al.
Publicado: (2016)

Biomarkers to quantify cell migration characteristics
por: Kwon, Sangwoo, et al.
Publicado: (2020)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells
por: Daker, Maelinda, et al.
Publicado: (2012)

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
por: Fu, Jiali, et al.
Publicado: (2021)

Hypothermia enhances induction of protective protein metallothionein under ischemia
por: Park, Youn Hee, et al.
Publicado: (2013)

Bismuth Porphyrin Antagonizes Cisplatin-Induced Nephrotoxicity via Unexpected Metallothionein-Independent Mechanisms
por: Wang, Runming, et al.
Publicado: (2020)

NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells
por: Huang, Zhenhua, et al.
Publicado: (2003)

Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin
por: Kapperman, Heather E., et al.
Publicado: (2018)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017)

Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer
por: Huang, Yajing, et al.
Publicado: (2020)

Caveolin-1 enhances brain metastasis of non-small cell lung cancer, potentially in association with the epithelial-mesenchymal transition marker SNAIL
por: Kim, Yeong-Jin, et al.
Publicado: (2019)

Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors
por: Kim, Eunhye, et al.
Publicado: (2020)

Aged garlic extract protects against oxidative stress and renal changes in cisplatin-treated adult male rats
por: Nasr, Ashraf Y, et al.
Publicado: (2014)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway
por: Liu, Bing, et al.
Publicado: (2017)

Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
por: Gong, Lian, et al.
Publicado: (2020)

Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway
por: Wei, Bin, et al.
Publicado: (2020)

Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells
por: Li, Chaojie, et al.
Publicado: (2021)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway
por: Li, Sheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a81ra2l833g2q056i5b3cbqj24